A randomized phase II/III study of ‘novel therapeutics’ versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612
Sarit Assouline,Laura C. Michaelis,Megan Othus,Annette E. Hay,Roland B. Walter,Meagan A. Jacoby,Mark A. Schroeder,Geoffrey L. Uy,Helen Wong,Faisal Cheema,Kendra Sweet,Adam S. Asch,Jijun Liu,Anna Moseley,Tracy Maher,Laura Kingsbury,Min Fang,Jerald P. Radich,Richard F. Little,Harry P. Erba
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
识字岭的岭
无极微光
8R60d8
tiptip
蓝莓橘子酱
916
菠菜
Twonej
BowieHuang
Winfred
科研狗
挖掘机
dew
pluto
乐空思
小黄人
wenxin
妮妮
Sea_U
皖公网安备34019202002308
